UNI-EN 69:Current report 69 re insiders transactions
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| | UNI - EN REPORT No | 69 | / | 2014 | | ||||||
| Date of issue: | 2014-06-23 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Current report 69 re insiders transactions | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 160 ust 4 Ustawy o obrocie - informacja o transakcjach osуb maj№cych dostкp do informacji poufnych | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| The Board of Directors of Sopharma AD (the “Company") announces that it was notified by Mr Ognian Donev, Chairman of the Board of Directors that the company “Donev Investments Holding AD" related to him, executed the following transactions related to shares in the Company: Date and time Operation Number of shares Unit price (BGN) 16.6.2014 Buy 500 4,430 17.6.2014 Buy 340 4,310 17.6.2014 Buy 500 4,395 18.6.2014 Buy 370 4,300 18.6.2014 Buy 180 4,300 18.6.2014 Buy 450 4,300 18.6.2014 Buy 50 4,420 19.6.2014 Buy 14 4,300 19.6.2014 Buy 399 4,300 19.6.2014 Buy 187 4,300 20.6.2014 Buy 500 4,150 20.6.2014 Buy 170 4,150 The transfer of the above-mentioned shares was executed on the Bulgarian Stock Exchange in Sofia (regulated market) by way of electronic trade. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Current report 69 re insiders transactions.doc Current report 69 re insiders transactions.doc | Current report 69 re insiders transactions | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2014-06-23 | Ognian Donev | Executive director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 9.0 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
